Daily archive
Health - Tuesday, March 31, 2026
AI-generated daily summary plus top ranked stories from the day.
Health headlines for Tuesday, March 31, 2026
Health headlines for 2026-03-31 focused on 3 major developments: 1) Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion (NYT Health) 2) STAT+: The HSA industry makes its MAHA pitch (STAT News) 3) Supreme Court Rejects Colorado Law Banning ‘Conversion Therapy’ for L.G.B.T.Q. Minors (NYT Health) Across these stories, coverage emphasized high-impact updates, policy shifts, and events with broad audience relevance. Together they provide a representative view of the day in health news before diving into each full report.
Why it matters: This snapshot shows where health attention concentrated on 2026-03-31, highlighting the themes, entities, and geographies that dominated publisher coverage. Because ranking blends freshness, engagement, and source diversity, it helps separate signal from noise. Use it as a quick daily briefing and then open the top stories for fuller context.
Key Points
3 highlights-
Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion
Sources: #1 NYT Health -
STAT+: The HSA industry makes its MAHA pitch
Sources: #2 STAT News -
Supreme Court Rejects Colorado Law Banning ‘Conversion Therapy’ for L.G.B.T.Q. Minors
Sources: #3 NYT Health
Top 10 Stories
Ranked by daily score-
#1 Score 66Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 BillionEli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.
-
#2 Score 63STAT+: The HSA industry makes its MAHA pitchA new lobbying group tied to the health savings account industry is pushing hard to make HSAs far more widely available.
-
#3 Score 55Supreme Court Rejects Colorado Law Banning ‘Conversion Therapy’ for L.G.B.T.Q. MinorsThe state and more than 20 others restrict therapists from trying to change the gender identity or sexual orientation of clients under 18.
-
#4 Score 49STAT+: HHS changes the U.S. health IT office’s name, and its purviewThe Trump administration is changing the name of the federal health IT office back to the Office of the National Coordinator.
-
#5 Score 46How the Internet Became the ‘Cookbook’ of the Drug TradeA baffling overdose death took investigators to the frontier of ultra-potent synthetic drugs. The clues were hauntingly familiar.
-
#6 Score 40STAT+: Baby KJ scientists hit speed bump in quest to scale custom gene editorThe scientists who treated Baby KJ say the FDA's strict standards will make it much harder to create bespoke gene editing for others.
-
#7 Score 36Supreme Court rules against Colorado ban on ‘conversion therapy’ for LGBTQ kidsThe Supreme Court on Tuesday ruled against a law banning “conversion therapy” for LGBTQ+ kids in Colorado, one of about two dozen states that ban the discredited practice.
-
#8 Score 35FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.’s WishesThe peptides, which are increasingly marketed as providing longevity and health benefits, were removed in 2023 from the agency’s list of products that compounding pharmacies can sell.
-
#9 Score 34STAT+: OpenEvidence inks deal with major health systemIn this edition of STAT Health Tech: New OpenEvidence's partnership, pressure on HHS over health record sharing, and K health has a bot.
-
#10 Score 29STAT+: Pharmalittle: We’re reading about pharma delaying launches in Europe, Lilly and Biogen deals, and moreDrugmakers are delaying launches of some new medicines in Europe as the industry grapples with U.S. pressure and pricing policy shifts from President Trump